These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35902718)

  • 1. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.
    Ye P; Li F; Wei Y; Zhang Y; Cui J; Dai R; Chen H; Xie J; Cai P
    Sci Rep; 2022 Jul; 12(1):12894. PubMed ID: 35902718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.
    Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
    Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
    Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
    Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
    Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
    Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
    Wei Q; Chen L; Sheng L; Nordgren H; Wester K; Carlsson J
    Int J Oncol; 2007 Sep; 31(3):493-9. PubMed ID: 17671674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors.
    Carlsson J; Shen L; Xiang J; Xu J; Wei Q
    Oncol Lett; 2013 Jan; 5(1):208-214. PubMed ID: 23255921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.
    Shen L; Shui Y; Wang X; Sheng L; Yang Z; Xue D; Wei Q
    BMC Cancer; 2008 Aug; 8():232. PubMed ID: 18700025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
    Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
    Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
    Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
    Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in HER2 expression between primary colorectal cancer and corresponding metastases.
    Shan L; Lv Y; Bai B; Huang X; Zhu H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2275-2281. PubMed ID: 30203148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues.
    Malinowsky K; Raychaudhuri M; Buchner T; Thulke S; Wolff C; Höfler H; Becker KF; Avril S
    PLoS One; 2012; 7(7):e40285. PubMed ID: 22792263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
    Frogne T; Laenkholm AV; Lyng MB; Henriksen KL; Lykkesfeldt AE
    Breast Cancer Res; 2009; 11(1):R11. PubMed ID: 19239686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.